Study on Aztreonam, Avibactam, and Metronidazole for Treating Infections in Neonates and Infants Under 9 Months with Gram-Negative Bacterial Infections

Registered drugNo placebo

Study on Aztreonam, Avibactam, and Metronidazole for Treating Infections in Neonates and Infants Under 9 Months with Gram-Negative Bacterial Infections

Registered drugNo placebo

Greece

Participants:0–17 years
Substances:Avibactam Sodium
Sponsor:Pfizer Inc.

Contact Research Centre

Amyotrophic lateral sclerosis

Not yet recruiting

Study on the Effectiveness and Safety of Masitinib with Riluzole for Patients with Amyotrophic Lateral Sclerosis (ALS)

Investigational

Study on the Effectiveness and Safety of Masitinib with Riluzole for Patients with Amyotrophic Lateral Sclerosis (ALS)

Investigational

Greece

Participants:18–64 years · 65+ years
Substances:Masitinib
Sponsor:Ab Science

Contact Research Centre

Breast cancer

Not yet recruiting

Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

Registered drugNo placebo

Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Anastrozole
Sponsor:Eli Lilly & Co.

Contact Research Centre

Ischaemic stroke

Not yet recruiting

Study on Redasemtide for Adults with Acute Ischemic Stroke Not Eligible for Standard Treatments

Investigational

Study on Redasemtide for Adults with Acute Ischemic Stroke Not Eligible for Standard Treatments

Investigational

Greece

Participants:18–64 years · 65+ years
Substances:Redasemtide
Sponsor:Shionogi B.V.

Contact Research Centre

Sjogren's syndrome

Not recruiting

Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Investigational

Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Investigational

Greece

Participants:18–64 years · 65+ years
Substances:Dazodalibep
Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Contact Research Centre

Other cities in Greece

The busiest research cities in the country

All 50 cities in Greece

Clinical research in Larissa

What the registry says about research in the country

01 Oncology Research

Advanced clinical trials focusing on head and neck cancer, lung cancer, and prostate cancer treatments. Studies evaluate novel therapeutic combinations and targeted approaches for improved patient outcomes.

Non-small cell lung cancer therapies
Metastatic prostate cancer treatments
Head and neck squamous cell carcinoma

Research emphasizes combination therapies and innovative treatment approaches for various cancer types.

02 Autoimmune Conditions

Comprehensive studies investigating treatments for systemic lupus erythematosus, Sjögren's syndrome, and other autoimmune disorders. Trials focus on evaluating new therapeutic agents and their long-term safety profiles.

Lupus management strategies
Sjögren's syndrome treatments
Inflammatory disease therapies

Research aims to develop more effective treatments for chronic autoimmune conditions.

03 Cardiovascular Research

Studies examining heart failure prevention and cardiovascular disease management. Trials evaluate new medications and combination therapies to reduce cardiovascular events and improve patient outcomes.

Heart failure prevention strategies
Cardiovascular risk reduction
Lipoprotein management

Focus on preventive measures and innovative treatments for cardiovascular conditions.

Back to Greece All countries